Truist raises Xencor price target to $40 from $29
Bullish analyst reassessment, supported by a separate same-day target increase; targets remain opinions.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst reassessment, supported by a separate same-day target increase; targets remain opinions.
What happened, with direct paths to the underlying reporting
Truist raised its XNCR price target about 38% to $40; the posted price was $28.52, roughly 40% below the new target. The same-day Wedbush increase to $45 provides additional positive analyst context.
Target: $40
Posted price: $28.52
Analyst firm: Truist Financial
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.